癌症相关成纤维细胞中的2型脱碘酶维持低分化与未分化甲状腺癌生长
研究探讨2型脱碘酶(D2)在低分化甲状腺癌(PDTC)和未分化甲状腺癌(ATC)肿瘤微环境中的作用。在鼠和人PDTC/ATC模型中,D2在癌症相关成纤维细胞(尤其炎症性CAFs)中高表达,药理学抑制D2可减少肿瘤生长并改变CAF组成;3D共培养球体中D2活性通过旁分泌环路增强局部甲状腺激素信号促进肿瘤细胞增殖。人PDTC类器官对甲状腺激素调节有反应,提示局部甲状腺激素代谢是潜在治疗靶点。
要点
- D2在PDTC/ATC的癌症相关成纤维细胞中高表达,尤其在炎症性CAFs中。
- 抑制D2可减少小鼠移植瘤生长并改变CAF谱与活化状态。
- D2通过旁分泌环路增强局部TH信号促进肿瘤细胞增殖。
核心结论
- D2是PDTC和ATC中基质-上皮交叉对话的关键介质,局部甲状腺激素代谢是潜在治疗靶点。
研究设计与样本
- 使用鼠和人PDTC/ATC模型分析D2在甲状腺癌细胞和CAFs(含iCAFs)中的表达。
- 通过小鼠移植瘤模型药理学抑制D2及共培养3D球体评估功能相关性。
- 使用人PDTC来源类器官测试对甲状腺激素调节的反应性。
主要发现
- D2在CAFs尤其iCAFs中高表达,超过癌症上皮细胞中的水平。
- 体内抑制D2导致肿瘤生长减少及CAF谱和活化改变。
- 3D共培养球体中D2活性通过旁分泌环路增强局部TH信号,对肿瘤细胞增殖必需。
- 表达D2的人PDTC类器官对TH调节有反应,T3对该情境下肿瘤生长有正向作用。
临床怎么用
- 局部甲状腺激素代谢(D2)可能作为PDTC和ATC的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poorly differentiated thyroid carcinoma (PDTC) and anaplastic thyroid carcinoma (ATC) are aggressive thyroid cancers with limited treatment options and poor prognosis. While the tumor microenvironment (TME), especially cancer-associated fibroblasts (CAFs), is known to support tumor growth, its metabolic role is not well understood. This study aimed to investigate the role of type 2 deiodinase (D2)-an enzyme converting thyroxine to active triiodothyronine (T3)-in sustaining a pro-tumorigenic TME in PDTC and ATC. METHODS: We analyzed D2 expression in both thyroid cancer epithelial cells and CAFs, including inflammatory CAFs (iCAFs), using murine and human PDTC/ATC models. Functional relevance was assessed through pharmacological inhibition of D2 in mouse xenograft models and coculture three-dimensional (3D) spheroids. The effects on tumor growth, CAF composition, and epithelial-stromal signaling were evaluated. In addition, human PDTC-derived organoids were used to test responsiveness to thyroid hormone (TH) modulation. RESULTS: D2 was found to be highly expressed in CAFs, particularly iCAFs, exceeding levels observed in cancer epithelial cells. In vivo inhibition of D2 led to reduced tumor growth and changes in CAF profiles and activation. In 3D coculture spheroids, D2 activity was essential for tumor cell proliferation via a paracrine loop that enhanced local TH signaling. Human PDTC organoids expressing D2 also responded to TH modulation, confirming a positive effect of T3 on tumoral growth in this context. CONCLUSIONS: We identified D2 as a key mediator of stromal-epithelial cross talk in PDTC and ATC and highlight local TH metabolism as a potential therapeutic target in these lethal cancers.
引用
- De Stefano MA, Luongo C, Porcelli T, et al. Type 2 Deiodinase in Cancer-Associated Fibroblasts is Required to Sustain Growth of Poorly and Undifferentiated Thyroid Cancer. Thyroid. 2025. PMID: 41335042. doi:10.1177/10507256251401458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。